Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study

BACKGROUND: Vaccination remains the most effective measure to prevent SARS-CoV-2 infection and worse outcomes. However, many myasthenia gravis (MG) patients are hesitant to receive vaccine due to fear of worsening. METHODS: MG patients were consecutively enrolled in two MG centers in North China. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong-Yan, Shao, Li-Yuan, Song, Min, Hu, Shi-Min, Yue, Yao-Xian, Li, Hai-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388926/
https://www.ncbi.nlm.nih.gov/pubmed/35990671
http://dx.doi.org/10.3389/fimmu.2022.923017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388926/
https://www.ncbi.nlm.nih.gov/pubmed/35990671
http://dx.doi.org/10.3389/fimmu.2022.923017

Ejemplares similares